Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy

Theodorus Kwast; B Têtu; B Candas; J Gomez; L Cusan; F Labrie

doi:10.1016/S0090-4295(98)00542-1

Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy

Theodorus Kwast, B Têtu, B Candas, J Gomez, L Cusan, F Labrie

Research output: Contribution to journal › Article › Academic › peer-review

64 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	523-529
Number of pages	7
Journal	Urology
Volume	53
DOIs	https://doi.org/10.1016/S0090-4295(98)00542-1
Publication status	Published - 1999
Externally published	Yes

Access to Document

10.1016/S0090-4295(98)00542-1

http://hdl.handle.net/1765/56022

Cite this

@article{dc8bc75a17b343d78e8d0be5b78e8c26,

title = "Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy",

author = "Theodorus Kwast and B T{\^e}tu and B Candas and J Gomez and L Cusan and F Labrie",

year = "1999",

doi = "10.1016/S0090-4295(98)00542-1",

language = "Undefined/Unknown",

volume = "53",

pages = "523--529",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy

AU - Kwast, Theodorus

AU - Têtu, B

AU - Candas, B

AU - Gomez, J

AU - Cusan, L

AU - Labrie, F

PY - 1999

Y1 - 1999

U2 - 10.1016/S0090-4295(98)00542-1

DO - 10.1016/S0090-4295(98)00542-1

M3 - Article

VL - 53

SP - 523

EP - 529

JO - Urology

JF - Urology

SN - 0090-4295

ER -